STD Testing Devices Market Professional Survey Report Industry: Key Trends

The global STD testing devices market is growing at a rapid pace. Market growth attributes to the rising prevalence of sexually transmitted diseases (STD), such as ST infections, chlamydia (CT), gonorrhea (NG), and others. Besides, increasingly emerging therapeutic options for the risk of sexually acquired HIV-1 infection play a causal role in the market development, complementing federal initiative to address the HIV epidemic.

Moreover, the increasing awareness about STDs and government initiatives & funding support promoting the diagnostic & treatment methods escalate the market growth. According to Market Research Future (MRFR), the global STD testing devices market valuation had reached USD 70.29 BN in 2018, which is poised to appreciate at 9.3% CAGR throughout the assessment period (2019-2025). The growing use of STD testing devices for hospitalized patients is a significant growth driver for the market.

On the other hand, unfavorable healthcare reforms are major factors likely to impede the growth of the market. Also, the lack of information about the symptoms and causes hamper the market growth extensively. Nevertheless, rising R&D activities to improve STD diagnostics and treatment procedures would support market growth during the review period. Additionally, government funding to drive R&D required discovering effective STD diagnostic kits, push the growth of the market.

Increasing medical clinics with ultrasound machines and prenatal care to provide STD diagnostics & treatment methods boost market growth. Additional factors substantiating market growth include growing healthcare expenditure, global population, and per capita healthcare expenses. The expansion of healthcare infrastructure, including dramatically increasing numbers of hospitals & clinics, pushes the growth of the market.

Global STD Testing Devices Market – Regional Analysis

North America dominates the global STD testing devices market. The largest market share attributes to the rising prevalence of sexually transmitted diseases. Besides, rising numbers of medical clinics with ultrasound machines, and prenatal care to provide testing and treatment for sexually transmitted diseases drive the market growth. The growing use of STD testing devices for hospitalized patients is a significant growth driver for the market.

The Asia Pacific STD testing devices market is growing rapidly. Factors such as increasing awareness for STDs and the diagnostic & treatment methods and government initiatives & funding support foster the regional market growth. Additionally, the growing manufacturing of testing devices, healthcare expenses, and a large population drive regional market growth. Furthermore, improving healthcare infrastructures push the growth of the APAC STD testing devices market.

Major Players:

Players leading the global STD testing devices market include Abbott (US), MedMira Inc. (Canada), Qaigen Inc. (US), Thermo Fisher Scientific (US), Cepheid (Danaher Corporation) (US), Hoffmann-La Roche AG (Switzerland), Diasorin S.p.A (Italy), Bio-Rad Laboratories, Inc. (US), bioMeriuex (France), Becton Dickinson and Company (US), Hologic, Inc. (US), GenePOC Inc. (Canada), Meridian Bioscience (US), and OraSure Technologies (US), among others.

Article source: https://article-realm.com/article/Sports-Recreation/13517-STD-Testing-Devices-Market-Professional-Survey-Report-Industry-Key-Trends.html